#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 16°C Tuesday 3 August 2021
Advertisement

The Explainer: Delivery woes, efficacy questions, and Brexit - what's going on with AstraZeneca?

We take a closer look on this week’s episode.

THE OXFORD/ASTRAZENECA VACCINE has been at the centre of numerous major news stories in recent months. 

News broke yesterday that the HSE said the Pfizer and Moderna vaccines are ‘preferential’ for the over 70s compared to the AstraZeneca vaccine. 

The vaccine was recommended for adults of all ages by the European Medicines Agency last week, but several countries had already flagged that they would not be advising it be administered to older people.

Last Friday we saw another issue pop up – where it appeared Europe wanted to trigger Article 16 in order to protect vaccine stocks. This move came amid a deepening row over the allocation of the Oxford/AstraZeneca vaccine after the company announced delays to its EU operations.

To take you through all of the above, and explain what’s been going on with AstraZeneca, this week we have reporters Michelle Hennessy and Ian Curran on The Explainer. 

Background reading:

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now


Source: The Explainer/SoundCloud

This episode was put together by presenter Sinéad O’Carroll, producers Aoife Barry and Nicky Ryan. Guests were reporters Michelle Hennessy and Ian Curran.

Read next:

COMMENTS (2)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a commentcancel